AUSTIN, Texas — Treatment with IV ketamine for pediatric Refractory Headache resulted in a 50% reduction in pain at discharge, with nearly two-thirds of patients not requiring rescue care within 1 month, according to a poster presentation.
“Patients with severe and refractory headaches often have few options for treatment despite ongoing pain and significant disability,” Scott Rosenthal, MD, a child neurology resident in the department of pediatrics at University of Colorado Anschutz Medical Campus, and colleagues wrote. “Ketamine has emerged as a potential therapeutic